4//SEC Filing
Beyer Russell P 4
Accession 0000899243-22-011666
CIK 0001833214other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:15 PM ET
Size
5.6 KB
Accession
0000899243-22-011666
Insider Transaction Report
Form 4
Beyer Russell P
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-16+6,000→ 6,000 totalExercise: $1.78Exp: 2032-03-16→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
- [F2]The shares underlying the option will vest in full on the one-year anniversary of March 16, 2022, the date the award was approved by the Company's board of directors.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001889754
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 9:15 PM ET
- Size
- 5.6 KB